INCIDENTAL DIAGNOSIS OF DISSEMINATED CYSTICERCOSIS IN A PATIENT WITH ALCOHOL-RELATED ACUTE PANCREATITIS: A CASE REPORT
DOI:
https://doi.org/10.53555/5h3zy812Keywords:
disseminated cysticercosis, calcified lesions, incidental finding, Taenia solium, acute pancreatitis, alcohol use.Abstract
Disseminated cysticercosis is a rare parasitic disease caused by Taenia solium larvae that involves multiple organ systems. While cysticercosis commonly affects the central nervous system, disseminated forms[1] with complete calcification of lesions are rare and often asymptomatic
Case
Presentation:
We report the case of a 52-year-old male from southern India with a history of chronic alcohol use and poorly managed diabetes who presented with acute abdominal pain and altered mental status. Laboratory investigations confirmed acute pancreatitis. Incidentally, CT and MRI revealed multiple calcified lesions in the brain, skeletal muscles, and soft tissues, consistent with disseminated calcified cysticercosis[2].
Clinical
Discussion:
The patient exhibited no active signs or symptoms of neurocysticercosis. No antiparasitic therapy was initiated[3]. Management focused on treating pancreatitis and advising on food hygiene and alcohol cessation.
Conclusion:
This case highlights the importance of recognizing incidental imaging findings suggestive of disseminated calcified cysticercosis and underscores the role of conservative management in the absence of active disease. Public health measures to ensure food hygiene and safe dietary practices remain essential to prevent Taenia soliuminfections[4].
References
1. Ganaraja HV, Mahadevan A, Saini J, et al. Disseminated cysticercosis in Indian scenario – experience from a teaching university hospital. Neurol India. 2022;70(3):1032–40.
2. Dabas S, Gupta V, Narula A. Disseminated cysticercosis: a case report and review of treatment protocols. BMJ Case Rep. 2022;15(3):e248603.
3. Wadia N, Desai S, Bhatt M. Disseminated cysticercosis. New observations, including CT scan findings and experience with treatment by praziquantel. Brain. 1988;111(3):597–614.
4. Garg RK. Drug treatment of neurocysticercosis. Natl Med J India. 1997;10(4):173–7.
5. Del Brutto OH, Roos KL, Coffey CS, García HH. Meta-analysis: cysticidal drugs for neurocysticercosis: albendazole and praziquantel. Ann Intern Med. 2006;145(1):43–51.
6. 6.Garcia HH, Gonzales I, Lescano AG, et al. Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomized controlled trial. Lancet Infect Dis. 2014;14(8):687–95.
7. 7.White AC Jr, Coyle CM, Rajshekhar V, Singh G, Hauser WA, Mohanty A, et al.Diagnosis and treatment of neurocysticercosis: 2017 clinical practice guidelines by the Infectious Diseases Society of America and the American Society of Tropical Medicine and Hygiene. Am J Trop Med Hyg. 018;98(4):945–66.
8. 8.Garg RK, Rizvi I, Chakravarty R, Malhotra HS, Kumar N. Treatment outcome in patients with disseminated cysticercosis: a systematic review of case reports and case series. Am J Trop Med Hyg. 2024;110(6):1080–8.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Journal of Population Therapeutics and Clinical Pharmacology

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.